RGRodrigo Guerrero

Rodrigo Guerrero

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rodrigo Guerrero has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Decade of Editorial Leadership: Advancing Colombia Médica as a Regional Scientific Platform

    by Luis Eduardo Bravo, Rodrigo Guerrero, Yezid Solarte, Lorena Matta, Lena Barrera, Enrique Herrera, Carlos Andrés Fandiño

    As Editor-in-Chief of Colombia Médica, Professor Mauricio Palacios Gómez has led a sustained process of editorial, technical, and scientific strengthening for more than a decade in one of the most influential biomedical journals in Latin America. Through timely, strategically structured, and conceptually solid editorials, he has charted a path of critical reflection and global projection on the role of scientific journals in contexts of academic, technological, and political transition. One of his most recent contributions,”The Art of Validating Science: Four Centuries of Peer Review”, clearly and elegantly synthesizes the historical trajectory of peer review and analyzes current challenges regarding quality, transparency, and equity in scientific publishing. This editorial continues a line of thought initiated a decade earlier with”Agreement to Build Better Scientific Journals in Colombia”, which represented a clear institutional stance by endorsing the San Francisco Declaration on Research Assessment (DORA), advocating for a fairer and more qualitative way of evaluating scientific output. In”How to Organize Scientific and Technological Information in Latin America?”, published in 2016, Professor Palacios proposed an integrative regional vision that emphasizes collaborative networks and open science as pillars of a new knowledge infrastructure. In 2018, his editorial, “The Uncertainty of Colombian Scientific Journals with Publindex,” issued a critical warning about systemic weaknesses in the national indexing model and became a key text for understanding the sustainability challenges faced by Colombian scientific journals. A year later, in” Editorial Advances of the Journal Colombia Médica”, he documented the journal’s evolution, including its digital transformation, growing international visibility, and consolidation as a regional benchmark in public health, clinical medicine, and biomedical sciences. In” What does Colombia require to earn a Nobel Prize in Medicine?”, he offered a reflective critique of the excessive use of bibliometric indicators. He advocated for more balanced and contextualized scientific evaluations.

  • Open Access

    Evaristo García Piedrahíta 1845-1921

    by Rodrígo Guerrero Velasco, Pedro Alejandro Rovetto

    Médico, salubrista, investigador, líder académico, social y político Esta breve reseña se propone dar a conocer la extraordinaria personalidad y logros de Evaristo García Piedrahíta, distinguido médico vallecaucano, quien vivió en el Siglo IXX, desconocido por la población general y aún por muchos profesionales de la salud. También busca destacar que en 1942 la Asamblea Departamental del Valle del Cauca ordenó que el hospital que estaba en construcción, llevara su nombre y que se colocara su efigie en la entrada del hoy llamado Hospital Universitario del Valle Evaristo García 1. A los pocos años de fundada la facultad de Medicina El hospital de San Juan de Dios era insuficiente para los ambiciosos planes de reforma de educación médica que promovían Gabriel Velásquez, Alfonso Ocampo y demás líderes de la naciente Facultad de Medicina de la Universidad del Valle. Por eso se propusieron terminar el hospital que estaba en construcción desde hacía muchos años, y finalmente lograron terminar la construcción. Su inauguración se hizo en 1956 en el hoy llamado Auditorio Carlos Manzano con presencia de autoridades de la ciudad y del departamento. Desde ese entonces el Evaristo es el Hospital insignia de la Universidad del Valle y por él han pasado distinguidos profesores y estudiantes y ahí se han realizado investigaciones de gran importancia nacional y mundial.

  • Open Access

    Improving accessibility to radiotherapy services in Cali, Colombia: cross-sectional equity analyses using open data and big data travel times from 2020

    by Luis Gabriel Cuervo, Carmen Juliana Villamizar, Daniel Cuervo, Pablo Zapata, Maria B. Ospina, Sara Marcela Valencia, Alfredo Polo, Ángela Suárez, Maria O. Bula, J. Jaime Miranda, et al.

    In this study, we evaluated and forecasted the cumulative opportunities for residents to access radiotherapy services in Cali, Colombia, while accounting for traffic congestion, using a new people-centred methodology with an equity focus. Furthermore, we identified 1–2 optimal locations where new services would maximise accessibility. We utilised open data and publicly available big data. Cali is one of South America's cities most impacted by traffic congestion.Methodology: Using a people-centred approach, we tested a web-based digital platform developed through an iterative participatory design. The platform integrates open data, including the location of radiotherapy services, the disaggregated sociodemographic microdata for the population and places of residence, and big data for travel times from Google Distance Matrix API. We used genetic algorithms to identify optimal locations for new services. We predicted accessibility cumulative opportunities (ACO) for traffic ranging from peak congestion to free-flow conditions with hourly assessments for 6–12 July 2020 and 23–29 November 2020. The interactive digital platform is openly available.Primary and secondary outcomes: We present descriptive statistics and population distribution heatmaps based on 20-min accessibility cumulative opportunities (ACO) isochrones for car journeys. There is no set national or international standard for these travel time thresholds. Most key informants found the 20-min threshold reasonable. These isochrones connect the population-weighted centroid of the traffic analysis zone at the place of residence to the corresponding zone of the radiotherapy service with the shortest travel time under varying traffic conditions ranging from free-flow to peak-traffic congestion levels. Additionally, we conducted a time-series bivariate analysis to assess geographical accessibility based on economic stratum. We identify 1–2 optimal locations where new services would maximize the 20-min ACO during peak-traffic congestion.Results: Traffic congestion significantly diminished accessibility to radiotherapy services, particularly affecting vulnerable populations. For instance, urban 20-min ACO by car dropped from 91% of Cali’s urban population within a 20-min journey to the service during free-flow traffic to 31% during peak traffic for the week of 6–12 July 2020. Percentages represent the population within a 20-min journey by car from their residence to a radiotherapy service. Specific ethnic groups, individuals with lower educational attainment, and residents on the outskirts of Cali experienced disproportionate effects, with accessibility decreasing to 11% during peak traffic compared to 81% during free-flow traffic for low-income households. We predict that strategically adding sufficient services in 1–2 locations in eastern Cali would notably enhance accessibility and reduce inequities. The recommended locations for new services remained consistent in both of our measurements.These findings underscore the significance of prioritising equity and comprehensive care in healthcare accessibility. They also offer a practical approach to optimising service locations to mitigate disparities. Expanding this approach to encompass other transportation modes, services, and cities, or updating measurements, is feasible and affordable. The new approach and data are particularly relevant for planning authorities and urban development actors.


  • Open Access

    Mortalidad por COVID-19 durante el plan de vacunación contra el virus SARS-CoV2 en Cali, Colombia

    by Carlos Reina, Miyerlandi Torres, Edgar Muñoz, Elvia Karina Grillo Ardila, Rodrigo Guerrero, Luis Eduardo Bravo

    El comportamiento de la pandemia de COVID-19 durante los tres picos registrados en Cali ha sido heterogéneo y la severidad de los contagios y decesos ha variado durante el tiempo. Cali con 2.2 millones de habitantes es la tercera ciudad mas poblada de Colombia, registra a la fecha (21-11-21) 285 mil casos confirmados y 7,474 muertes por la infección. El plan de vacunación contra el SARS-CoV2 iniciado en febrero de 2021, ha inmunizado en Cali 1.54 millones de personas. Al igual que en el resto del país, el desarrollo del plan de vacunación en Cali coincidió con el tercer pico de la pandemia, el más prolongado y de mayor mortalidad; así, como con múltiples movilizaciones sociales de cientos de manifestantes agolpados en las calles entre mayo y junio del 2021, en protesta a una reforma tributaria impopular promulgada por el gobierno nacional. En Cali el plan de vacunación también se afectó por falta de acceso a servicios de salud y puntos de vacunación por bloqueos registrados en diferentes territorios de la ciudad. Al final del tercer pico, el país afrontó dificultades para continuar con el plan de vacunación por barreras al acceso de biológicos en el mercado internacional.


  • Open Access

    Héctor Abad-Gómez (1921-1987): médico, educador y defensor de los derechos humanos

    by Rodrigo Guerrero-Velasco, Giovanni Apráez-Ippolito


  • Open Access

    Reply to a letter from Robert Colebunders entitled COVID-19: The African Enigma

    by Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero

    We thank Dr. Colebunders for his comments regarding our manuscript. Our study was an ecological study prompted by the low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some African countries. We agree with Dr. Colebunders that other factors could explain the observed association between APOC countries and COVID-19 mortality. However, these unmeasured confounders would have to be strongly associated with Covid-19 mortality to explain the observed 28% reduction. In updated information, as of 12-17-20, APOC countries had a 42% lower risk of death than the non-APOC countries, adjusted for confounders. (Not published) Hellwig et al., in addition to reporting similar findings to ours for African and Asian countries, surmised that they may be connected to ivermectin’s ability to inhibit SARS-CoV-2 replication suggesting other pathways must exist to explain the persistence of such an inhibitory effect after serum levels of ivermectin have declined. As mentioned by Mbow et al. “, it is increasingly recognized that the immune system is shaped not only by genetics but also by environmental factors, such as exposure to microorganisms and parasites. This educates the immune system to protect against invading pathogens not only specifically but also nonspecifically through, for example, “trained immunity,” which involves the reprogramming of innate cells that, on secondary encounter with a pathogen, can show a stronger response.” Those infections, such as onchocerciasis, may downregulate immune responses and potentially inactivate the inflammatory signalling pathways that may induce acute respiratory distress syndrome (ARDS), one of the causes of death in COVID-19 infected persons, seems very attractive explanation.

  • Open Access

    COVID-19: The Ivermectin African Enigma

    by Rodrigo Guerrero, Luis Eduardo Bravo, Edgar Muñoz, Elvia Karina Grillo Ardila, Esteban Guerrero

    Introduction: The low frequency of cases and deaths from the SARS-CoV-2 COVID-19 virus in some countries of Africa has called our attention to the unusual behavior of this disease. Aims: Describe SARS-CoV2 infection and death rates in African countries that participated in an intensive Ivermectin mass campaign carried out to control onchocerciasis and compare them with those of countries that did not participate. Methods: Data from 19 countries that participated in the WHO sponsored African Programme for Onchocerciasis Control (APOC), from 1995 until 2015, intended to treat over 90 million people annually and protect an at-risk population of 115 million, were compared with thirty-five (Non-APOC), countries that were not included. Information was obtained from https://www.worldometers.info/coronavirus/ database. Results After controlling for different factors including the Human Development Index, APOC countries, show statistically significant 28% lower mortality (0.72 IC 95% 0,67-0,78) and 8% lower rate of infection (0.92 IC95% 0,91-0,93) due to COVID-19. Conclusions: The incidence in mortality rates and the number of cases is significantly lower among the APOC countries compared to non-APOC countries. That a mass public health preventive campaign against COVID-19 may have taken place, inadvertently, in some African countries with massive community ivermectin use is an attractive hypothesis. Additional studies are needed to confirm it.


  • Open Access

    Mathematical models and the coronavirus, COVID-19

    by Elvia Karina Grillo Ardila, Luis Eduardo Bravo Ocaña, Rodrigo Guerrero, Julián Santaella-Tenorio

    Currently, there are several mathematical models that have been developed to understand the dynamics of COVID-19 infection. However, the difference in the sociocultural contexts between countries requires the specific adjustment of these estimates to each scenario. This article analyses the main elements used for the construction of models from epidemiological patterns, to describe the interaction, explain the dynamics of infection and recovery, and to predict possible scenarios that may arise with the introduction of public health measures such as social distancing and quarantines, specifically in the case of the pandemic unleashed by the new SARS-CoV-2/COVID-19 virus. Comment: Mathematical models are highly relevant for making objective and effective decisions to control and eradicate the disease. These models used for COVID-19 have supported and will continue to provide information for the selection and implementation of programs and public policies that prevent associated complications, reduce the speed of the virus spread and minimize the occurrence of severe cases of the disease that may collapse health systems.


  • Open Access

    Efecto del control del crimen organizado sobre la violencia homicida en Cali (Colombia)

    by Universidad del Valle Instituto Cisalva Y Escuela de Salud Pública, Andrés Fandiño-Losada, Rodrigo Guerrero-Velasco, Universidad del Valle Y Exalcalde de Cali Instituto Cisalva, Jorge H. Mena-Muñoz, Universidad del Valle Instituto Cisalva, María Isabel Gutiérrez-Martínez

    Desde 1993, cuando se estableció el Sistema de Vigilancia de Muertes de Causas Externas (SVMCE) –hoy el Observatorio de Seguridad–, existe un registro conf...